InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (11 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Levy Adam Scott, Chief Financial Officer. Director active across 1 company, notably Mineralys Therapeutics, Inc.. In total, 12 filings have been logged. Split: 1 buy · 11 sells. Total volume traded: €3.2m. Activity tracked since 14 February 2023. The latest transaction was disclosed on 12 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
10,758 shares@ US$32.136420.6% of flowCommon StockSEC:0001693134-26-000002
10,758 shares@ US$32.13640.013% mcap20.6% of flowCommon StockSEC:0001693134-26-000002:0
7,366 shares@ US$41.90210.012% mcap18.5% of flowCommon StockSEC:0001933414-25-000130:0
7,366 shares@ US$41.902118.5% of flowCommon StockSEC:0001933414-25-000130
12,946 shares@ US$14.043210.9% of flowCommon StockSEC:0001933414-25-000081
12,946 shares@ US$14.04320.0069% mcap10.9% of flowCommon StockSEC:0001933414-25-000081:0
10,757 shares@ US$12.05583.6% of flowCommon StockSEC:0001933414-25-000046:0
10,657 shares@ US$9.09273.0% of flowCommon StockSEC:0001933414-25-000005:0
10,757 shares@ US$13.57294.2% of flowCommon StockSEC:0001933414-24-000047:0
10,757 shares@ US$13.14444.1% of flowCommon StockSEC:0001933414-24-000034:0
96,815 shares@ US$12.939336.7% of flowCommon StockSEC:0001933414-24-000027:0
6,250 shares@ US$16.002.9% of flowCommon StockSEC:0001628280-23-003924:0
Ideal exit: 11 Nov 2023 (T+270)
12 of 12 declarations
About Levy Adam Scott
Adam Scott Levy is the Chief Financial Officer and Secretary of Mineralys Therapeutics, Inc. He is responsible for the company's financial management, including budgeting and financial reporting. His role is crucial in ensuring financial transparency and supporting Mineralys's growth strategy.
